08/12/2026
When Pat's son, Will, was diagnosed with high-risk neuroblastoma (HRNB) at just 6 months old, their family was told there were no more options. Pat refused to accept that answer. Through years of advocacy, fundraising, and supporting clinical research, Pat helped fight for new treatment options for children facing HRNB, includin IWILFIN (eflorinithine). Today, Will is 21 years old and thriving.
Watch their story at https://bit.ly/43ywnvY
Please see the full Prescribing Information and Patient Information at https://bit.ly/4egPnns